19 Jersey Street
About 1CellBiO1CellBiO Inc. is a leader in products enabling high-throughput, single-cell biology, including inDrop™ for high throughput single cell RNA sequencing.
May 15, 2016
Founders: Allon M. Klein, Marc W. Kirschner, Dave A. Weitz, Colin J. H. Brenan, Ph.D., Fred Dom, M.Sc.—, and Linas Mazutis
CEO: Colin J. H. Brenan, Ph.D.
CFO: Fred Dom, M.Sc.
Please click here for 1CellBiO's technology.
Please click here for 1CellBiO's job opportunities.
5 articles with 1CellBiO
1CellBio to Offer Dual-Indexed Library Design Capability for inDrop™ System to Improve Throughput and Cost-Effectiveness for Large-Scale Single-Cell RNA Sequencing Studies
1CellBio, Inc. , announced today a new dual indexed library design capability that improves costs, throughput and data quality for its inDrop™ single-cell RNA sequencing (scRNA-seq) System. The TruDrop capability was developed in collaboration w
1CellBio to Offer Early Access to Novel Targeted Cell Selection and Sequencing Capabilities Demonstrated in New Nature Biotechnology Publication
Company to pursue co-development collaborations for diverse clinical, pharmaceutical and biological research applications
4/18/2019The BioIT World Conference & Expo is going on in Boston, Massachusetts, highlighting companies and breakthroughs working on the data end of life sciences, whether that’s blockchain, artificial intelligence, machine learning, data science, deep learning or others.
Powerful Single Cell Bioinformatics Solution in a Graphical User Interface
1CellBio and the Open Medicine Institute Join Forces to Demonstrate Power of Single-Cell RNA Sequencing in Precision Medicine Applications
inDrop™ System selected to generate predictive multi-omic clinical research data for undiagnosed conditions with immune dysfunction